The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8633196, 14::US8633196, 5 ID: ALA3648893
Chembl Id: CHEMBL3648893
PubChem CID: 49849092
Max Phase: Preclinical
Molecular Formula: C25H31N5O7S2
Molecular Weight: 577.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(COc2ccc(S(=O)(=O)NC[C@@H](C(=O)NO)N3CCN(S(C)(=O)=O)CC3)cc2)c2ccccc2n1
Standard InChI: InChI=1S/C25H31N5O7S2/c1-18-15-19(22-5-3-4-6-23(22)27-18)17-37-20-7-9-21(10-8-20)39(35,36)26-16-24(25(31)28-32)29-11-13-30(14-12-29)38(2,33)34/h3-10,15,24,26,32H,11-14,16-17H2,1-2H3,(H,28,31)/t24-/m0/s1
Standard InChI Key: IVLLKNCAVYHIFI-DEOSSOPVSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 577.69Molecular Weight (Monoisotopic): 577.1665AlogP: 0.85#Rotatable Bonds: 10Polar Surface Area: 158.24Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.70CX Basic pKa: 5.02CX LogP: 0.13CX LogD: 0.10Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -1.49
References 1. (2014) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics, 2. (2016) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics,